| 1 |
34641548 | Selected Class of Enamides Bearing Nitro Functionality as Dual-Acting with Highly Selective Monoamine Oxidase-B and BACE1 Inhibitors. | 2021 Oct 3 |
1 |
| 2 |
32443652 | Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors. | 2020 May 18 |
1 |
| 3 |
31550216 | Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer's Disease. | 2019 |
1 |
| 4 |
29195801 | Discovery of potent and reversible MAO-B inhibitors as furanochalcones. | 2018 Mar |
1 |
| 5 |
29958546 | Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy. | 2018 Jun 29 |
1 |
| 6 |
30143367 | Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase. | 2018 Sep 15 |
1 |
| 7 |
17570647 | Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death. | 2008 Jan |
2 |
| 8 |
12359039 | Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation. | 2002 Oct |
2 |
| 9 |
10688633 | Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme. | 2000 Mar |
1 |
| 10 |
10927030 | Antioxidant activity of the monoamine oxidase B inhibitor lazabemide. | 2000 Sep 1 |
3 |
| 11 |
10408736 | Recent developments in the drug treatment of Alzheimer's disease. | 1999 May |
1 |
| 12 |
10626094 | Safety study of lazabemide (Ro19-6327), a new MAO-B inhibitor, on cardiac arrhythmias and blood pressure of patients with Parkinson's disease. | 1999 Nov-Dec |
1 |
| 13 |
9466361 | In vivo properties of N-(2-aminoethyl)-5-halogeno-2-pyridinecarboxamide 18F- and 123I-labelled reversible inhibitors of monoamine oxidase B. | 1998 Jan |
2 |
| 14 |
9056051 | Pharmacokinetics and pharmacodynamics of single and multiple doses of the MAO-B inhibitor lazabemide in healthy subjects. | 1997 Jan |
4 |
| 15 |
9116589 | Densities of I2-imidazoline receptors, alpha 2-adrenoceptors and monoamine oxidase B in brains of suicide victims. | 1997 Jan |
1 |
| 16 |
9394121 | The density of monoamine oxidase B sites is not altered in the postmortem brain of alcoholics. | 1997 Nov |
2 |
| 17 |
8665924 | Investigation on the structure of the active site of monoamine oxidase-B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis. | 1996 Mar 15 |
2 |
| 18 |
7601156 | Structure/function relationships of mitochondrial monoamine oxidase A and B chimeric forms. | 1995 Jun 15 |
1 |
| 19 |
7816197 | Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. | 1994 Sep |
2 |
| 20 |
7917773 | Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B. | 1994 Jun |
3 |
| 21 |
8155011 | A controlled trial of lazabemide (Ro 19-6327) in levodopa-treated Parkinson's disease. Parkinson Study Group. | 1994 Apr |
3 |
| 22 |
8374913 | Symptomatic anti-parkinsonian effects of monoamine oxidase-B inhibition: comparison of selegiline and lazabemide. | 1993 Aug |
2 |
| 23 |
8395564 | Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites. | 1993 Sep |
1 |
| 24 |
8413955 | Monoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease: the degree and reversibility of human brain MAO B inhibition by Ro 19 6327. | 1993 Oct |
5 |
| 25 |
8489205 | A controlled trial of lazabemide (RO19-6327) in untreated Parkinson's disease. Parkinson Study Group. | 1993 Apr |
3 |
| 26 |
1904879 | Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomography. | 1991 Jul |
1 |
| 27 |
1906004 | Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327. | 1991 |
1 |
| 28 |
2122653 | Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans. | 1990 |
1 |
| 29 |
2380287 | Determination of the monoamine oxidase B inhibitor Ro 19-6327 in plasma by high-performance liquid chromatography using precolumn derivatization with fluorescamine and fluorescence detection. | 1990 May 16 |
2 |
| 30 |
3126263 | [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes. | 1988 Apr |
2 |